Boston Scientific Corp (BSX)
72.91
+3.92
(+5.68%)
USD |
NYSE |
Apr 24, 16:00
73.11
+0.20
(+0.27%)
Pre-Market: 06:28
Boston Scientific Free Cash Flow: 1.703B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.703B |
| September 30, 2023 | 1.615B |
| June 30, 2023 | 1.422B |
| March 31, 2023 | 1.172B |
| December 31, 2022 | 914.00M |
| September 30, 2022 | 524.00M |
| June 30, 2022 | 583.00M |
| March 31, 2022 | 918.00M |
| December 31, 2021 | 1.316B |
| September 30, 2021 | 1.602B |
| June 30, 2021 | 1.737B |
| March 31, 2021 | 1.374B |
| December 31, 2020 | 986.00M |
| September 30, 2020 | 1.131B |
| June 30, 2020 | 997.00M |
| March 31, 2020 | 937.00M |
| December 31, 2019 | 1.375B |
| September 30, 2019 | 621.00M |
| June 30, 2019 | 651.00M |
| March 31, 2019 | 51.00M |
| December 31, 2018 | -178.00M |
| September 30, 2018 | 496.00M |
| June 30, 2018 | 457.00M |
| March 31, 2018 | 1.153B |
| December 31, 2017 | 976.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 790.00M |
| June 30, 2017 | 338.00M |
| March 31, 2017 | 471.00M |
| December 31, 2016 | 674.00M |
| September 30, 2016 | 368.00M |
| June 30, 2016 | 808.00M |
| March 31, 2016 | 479.00M |
| December 31, 2015 | 178.00M |
| September 30, 2015 | 443.00M |
| June 30, 2015 | 395.00M |
| March 31, 2015 | 611.00M |
| December 31, 2014 | 984.00M |
| September 30, 2014 | 808.00M |
| June 30, 2014 | 706.00M |
| March 31, 2014 | 822.00M |
| December 31, 2013 | 821.00M |
| September 30, 2013 | 984.00M |
| June 30, 2013 | 1.005B |
| March 31, 2013 | 1.013B |
| December 31, 2012 | 1.032B |
| September 30, 2012 | 964.00M |
| June 30, 2012 | 1.052B |
| March 31, 2012 | 1.005B |
| December 31, 2011 | 693.00M |
| September 30, 2011 | 818.00M |
Free Cash Flow Range, Past 5 Years
524.00M
Minimum
Sep 2022
1.737B
Maximum
Jun 2021
1.136B
Average
1.131B
Median
Sep 2020
Free Cash Flow Benchmarks
| Stryker Corp | 3.136B |
| Abbott Laboratories | 5.059B |
| Edwards Lifesciences Corp | 629.50M |
| Intuitive Surgical Inc | 595.80M |
| Axonics Inc | -5.566M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 957.00M |
| Cash from Investing (Quarterly) | -1.053B |
| Cash from Financing (Quarterly) | 15.00M |
| Free Cash Flow Per Share (Quarterly) | 0.4673 |
| Free Cash Flow to Equity (Quarterly) | 488.00M |
| Free Cash Flow to Firm (Quarterly) | 732.91M |
| Free Cash Flow Yield | 1.60% |